Navigation Links
Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
Date:11/8/2007

SEATTLE, Nov. 8 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced presentation of positive data from a Phase IIb study that showed that Trubion's TRU-015 for rheumatoid arthritis (RA) provided statistically significant efficacy after a single infusion of 800 mg or 1,600 mg. In addition, Trubion also announced presentation of data showing that repeat administration with TRU-015 was well tolerated and resulted in a consistent pharmacokinetic (PK) and pharmacodynamic (PD) profile. Trubion is co-developing TRU-015 with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), for the treatment of rheumatoid arthritis.

These data will be presented during two poster sessions at the annual meeting of the American College of Rheumatology (ACR) on Nov. 8 and 9, 2007. The posters are available in the Events section of Trubion's Web site at http://investors.trubion.com/events.cfm.

"TRU-015's ability to significantly improve RA signs and symptoms following a single infusion could represent a new level of convenience for patients and physicians. These results also suggest that clinical responses may be maintained during B-cell recovery," said Peter Thompson, M.D., FACP, president, chief executive officer and chairman of Trubion. "We and our partner have agreed on a design for our next study that we believe could be supportive of a registration package, and we look forward to TRU
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
(Date:9/18/2014)... , Sept. 18, 2014  A $3 million grant ... the University of Michigan to establish a national center ... Glenn Center for Aging Research at U-M will focus ... can slow the effects of aging and postpone diseases ... aging that can help develop medications that may help ...
Breaking Medicine Technology:Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... April 25, 2011 The ophthalmic therapeutics company Xcovery ... and CEO, and Dr. Ken Mandell, President and COO, ... Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale ... of a Serial Entrepreneur recounts his repeated success ...
... April 25, 2011 The 2010 Pharmacy Today ... American Pharmacists Association , reveals pharmacists believe that ... was recommended by their pharmacist, 92% of pharmacists walk ... a product selection and the average patient consult takes ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 3
(Date:9/18/2014)... "Medical staff need better ways to provide quick ... privacy," said one of two inventors from Hialeah, Fla. ... supply caregivers with the equipment they need to do ... The Helper to make it easier to reposition a ... his or her side. It also securely stabilizes the ...
(Date:9/18/2014)... 2014 It’s been just a few short ... pending bunion splint to website visitors, but already the response ... was absolutely delighted. It is perfect and I find it ... them. THANK YOU FOR LISTENING!!!" Another user compared the ... hole used to slip to the end of my toe. ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Companies in ... refine carbon dioxide, selling it to downstream industries in ... for carbon dioxide are food and beverage manufacturers. Food ... as fruits, vegetables or pizzas. The gas is also ... use the compound to carbonate soft drinks, beer and ...
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, ... waiting times, patients seeking care at larger urban hospitals are ... those seen at smaller or more rural facilities, new research ... provide timely emergency care varies dramatically across hospitals in the ... research, Dr. Renee Hsia, an associate professor at the University ...
(Date:9/18/2014)... Sept. 18, 2014 (HealthDay News) -- Daily supplements of ... against the development of age-related cataracts among men, a ... that one or both could help prevent cataracts. To ... Hospital and Harvard Medical School in Boston, and his ... selenium and vitamin E. The trial was initially designed ...
Breaking Medicine News(10 mins):Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2
... MONDAY, Oct. 17 (HealthDay News) -- For years, nutritionists ... eat." Now, new research suggests this adage might even ... observation stems from a pair of studies slated for presentation ... in Orlando, Fla., both of which highlight an apparent linkage ...
... MASS. October 17, 2011 The Institute for ... announced Sharon K. Inouye, M.D., M.P.H., has been elected ... independent, nonprofit organization that works outside of government to ... the public. Inouye is the Director of the ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... is available in French and Spanish . ... than other women. Furthermore, the likelihood of developing breast cancer is ... of the main conclusions drawn in an article recently published in ... Granada research group CTS 367, coordinated by the Nursery Department professor ...
... Jenifer Goodwin HealthDay Reporter , SATURDAY, Oct. 15 ... hospital emergency departments don,t believe their weight poses a risk ... them otherwise, a new study finds. Researchers asked 450 ... at Shands at the University of Florida two questions: Do ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) -- Is ... so, says a new study that finds a link between ... However, the research doesn,t confirm that exposure to trash-talking ... explain why non-aggressive cussing might be a bad thing. And ...
Cached Medicine News:Health News:Healthier Diet, Stronger Sperm? 2Health News:Healthier Diet, Stronger Sperm? 3Health News:Hebrew SeniorLife's Dr. Sharon K. Inouye elected to Institute of Medicine 2Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Obese women have higher risk of suffering breast cancer 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4Health News:Profanity on TV Linked to Foul-Mouthed Kids 2
... for Candida albicans in only five ... two enzyme color reactions to produce ... read. AlbiQuicktm is performed on a ... Incubation time is only five minutes ...
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
... meridianEMR is a revolutionary "blended model EMR ... medical records in your office and on-line ... of physicians and software engineers, meridianEMR combines ... create a highly modular medical EMR that ...
... an Automated Digital Cell Morphology and Informatics ... and transmission of White & Red Blood ... blood smears can be loaded at once, ... 60 per hour depending on the tests ...
Medicine Products: